Covid Vaccines Found to Increase Risk of Cardiac Arrest Incidences
In a recent study published in the prestigious medical journal, Frontiers in Immunology, researchers led by Dr. Rolf Schreckenberg and his team from Justus-Liebig University Gießen and Hannover Medical School have shed light on a potential mechanism behind the reported cardiac events following mRNA vaccinations.
The study focuses on the behaviour of the spike protein produced in response to mRNA vaccines, such as those from Pfizer/BioNTech and Moderna. Within hours of receiving the injection, the spike proteins start clumping together into large, sticky aggregates inside the cells. This intracellular aggregation of spike protein subunits plays a key role in the development of myocarditis and other related inflammatory cardiac events following vaccination.
However, it's important to note that the specific study does not directly confirm that spike protein aggregation in heart cells causes damage. Instead, it alludes to the spike protein interacting with cardiovascular receptors, potentially disrupting heart function. This disruption could contribute to cardiovascular complications such as blood pressure issues, arrhythmias, or inflammation after vaccination or infection.
The findings add to the growing concerns about the potential for cardiac damage caused by mRNA vaccines. The researchers found inconsistencies with the formation of S2 subunits, another crucial component of the spike, which varied depending on the type of cell and the specific "vaccine" used. This finding contributes to the growing body of evidence that requires further investigation into the potential risks associated with mRNA vaccines.
The study reveals that the mechanism serves as a trigger behind myocarditis and other cardiac events reported following mRNA vaccination. While the S1 subunit escapes the cells and moves into the surrounding environment, other spike protein components, including the sticky aggregates, remain trapped inside the heart cells.
The manufacturers and health authorities must continue to monitor these risks and ensure transparency as more data becomes available. The research underscores the need for more research into the long-term effects of these vaccines, particularly as more data emerges about their impact on different age groups and underlying health conditions.
While the specific study in Frontiers in Immunology discussing spike protein aggregation in heart cells in relation to COVID-19 mRNA vaccines and cardiac damage was not directly identified in the provided search results, other reports discuss rare inflammatory cardiac conditions following mRNA vaccination, indicating that cardiac inflammation is a recognized though infrequent adverse event.
In summary, the study in Frontiers in Immunology alludes to the spike protein interacting with cardiovascular receptors, potentially disrupting heart function, but does not definitively conclude spike protein aggregation in heart cells causes damage. Further detailed mechanistic and clinical investigations are needed to clarify the extent and significance of spike protein-related cardiac effects post-mRNA vaccination.
- The study emphasizes the need for more research in the realm of health-and-wellness, specifically focusing on the science behind mRNA vaccines and their potential impact on cardiovascular-health, particularly in relation to medical-conditions such as myocarditis.
- The researchers have uncovered the truth about the behavior of spike proteins produced in response to mRNA vaccines, revealing that this protein may interact with cardiovascular receptors, leading to possible health issues related to articles like myocarditis.
- The publication of this study in the prestigious medical journal, Frontiers in Immunology, has raised concerns about the potential risks associated with mRNA vaccines, generating discussions surrounding the health implications of these vaccines and the need for continued transparency and monitoring by medical-authorities and manufacturers.
